Loading...
|
ab24680 |
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Cell Biology >> Proteolysis / Ubiquitin >> Proteasome / Ubiquitin >> Ubiquitin E2s and E3s >> RING Finger E3 Ligase
Anti-RNF8 antibody
See all RNF8 products (4) ...
Rabbit polyclonal to RNF8
This antibody recognises a single clean band representing RNF8.
ICC/IF, ICC, WBmore details
Reacts with
Human
Synthetic peptide conjugated to KLH derived from within residues 150 - 250 of Human RNF8.
(Peptide available as ab24680.)
This antibody gave a positive signal in Hela Whole Cell, Hela Nuclear and HEK293 Whole Cell Lysates
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: 0.02% Sodium Azide
Constituents: 1% BSA, PBS, pH 7.4
Concentration information loading...
Immunogen affinity purified
Polyclonal
IgG
Our Abpromise guarantee covers the use of ab4183 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ICC/IF: Use at an assay dependent dilution.
ICC: Use at an assay dependent dilution.
WB: Use a concentration of 1 - 2 µg/ml.Detects a band of approximately 60 kDa (predicted molecular weight: 55.5 kDa).
E3 ubiquitin-protein ligase required for assembly of repair proteins to sites of DNA damage. Catalyzes the 'Lys-63'-linked ubiquitination of histone H2A and H2AX. Following DNA double-strand breaks (DSBs), it is recruited to the sites of damage by ATM-phosphorylated MDC1, mediates the ubiquitination of histones H2A and H2AX, thereby promoting the formation of TP53BP1 and BRCA1 ionizing radiation-induced foci (IRIF). Promotes the formation of 'Lys-63'-linked polyubiquitin chains and functions with the specific ubiquitin-conjugating UBE2N/UBC13. Substrates that are polyubiquitinated at 'Lys-63' are usually not targeted for degradation. Enforces the G2/M DNA damage checkpoint. Controls the recruitment of UIMC1-BRCC3 (RAP80-BRCC36) and PAXIP1/PTIP to DNA damage sites following DNA double-strand breaks (DSBs). Ubiquitination of histone H2A requires UBE2N but not MMS2 (UBE2V2). May also ubiquitinate histone H2B. Catalyzes the 'Lys-63'-linked ubiquitination of PCNA. May be required for proper exit from mitosis after spindle checkpoint activation and may regulate cytokinesis. May play a role in the regulation of RXRA-mediated transcriptional activity. Not involved in RXRA ubiquitination by UBE2E2.
Ubiquitous. In fetal tissues, highest expression in brain, thymus and liver. In adult tissues, highest levels in brain and testis, lowest levels in peripheral blood cells.
Protein modification; protein ubiquitination.
Belongs to the RNF8 family.
Contains 1 FHA domain.
Contains 1 RING-type zinc finger.
Low levels at the G1-S boundary increase in intensity during S phase and until the end of the G2 phase. Abruptly decreases in late mitosis (at protein level). Barely detectable in anaphase.
The FHA domain specifically recognizes and binds ATM-phosphorylated MDC1 and Thr-4827 phosphorylated HERC2.
Autoubiquitinated through 'Lys-48' and 'Lys-63' of ubiquitin. 'Lys-63' polyubiquitination is mediated by UBE2N. 'Lys-29'-type polyubiquitination is also observed, but it doesn't require its own functional RING-type zinc finger.
Nucleus. Midbody. Following DNA double-strand breaks, recruited to the sites of damage. During prophase, concomitant with nuclear envelope breakdown, localizes throughout the cell, with a dotted pattern. In telophase, again in the nucleus and also with a discrete dotted pattern in the cytoplasm. In late telophase and during cytokinesis, localizes in the midbody of the tubulin bridge joining the daughter cells. Does not seem to be associated with condensed chromosomes at any time during the cell cycle.
Target information above from: UniProt accessionO76064
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - Anti-RNF8 antibody (ab4183)

Lane 1 : Anti-RNF8 antibody (ab4183) at 1/500 dilution
Lane 2 : Anti-RNF8 antibody (ab4183) at 1/1000 dilution
Lane 1 : HeLa nuclear extract
Lane 2 : HeLa nuclear extract
Performed under reducing conditions.
Predicted band size : 55.5 kDa
Observed band size : 60 kDa (why is the actual band size different from the predicted?)
Immunocytochemistry - Anti-RNF8 antibody (ab4183)

HeLa cells incubated with ab4183 (1/200). The RNF8 antibody gives a relatively weak yet predominantly nuclear staining pattern in interphase nuceli. ab4183 staining is shown in green. The cells were counterstained with DAPI (red).
Kirk McManus, University of British Columbia
Western blot - RNF8 antibody (ab4183)

All lanes : Anti-RNF8 antibody (ab4183) at 1 µg/ml
Lane 1 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate
Lane 2 : HeLa (Human epithelial carcinoma cell line) Nuclear Lysate
Lane 3 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate
Lane 4 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate with RNF8 peptide (ab24680) at 1 µg/ml
Lane 5 : HeLa (Human epithelial carcinoma cell line) Nuclear Lysate with RNF8 peptide (ab24680) at 1 µg/ml
Lane 6 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate with RNF8 peptide (ab24680) at 1 µg/ml
Lysates/proteins at 20 µg per lane.
Secondary
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Performed under reducing conditions.
Predicted band size : 55.5 kDa
Observed band size : 60 kDa (why is the actual band size different from the predicted?)
Exposure time : 3 minutes
This product has been referenced in:
See all 7 publications for this product
Publishing research using ab4183? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:

Lane 1 : Anti-RNF8 antibody (ab4183) at 1/500 dilution
Lane 2 : Anti-RNF8 antibody (ab4183) at 1/1000 dilution
Lane 1 : HeLa nuclear extract
Lane 2 : HeLa nuclear extract
Performed under reducing conditions.
Predicted band size : 55.5 kDa
Observed band size : 60 kDa (why is the actual band size different from the predicted?)

HeLa cells incubated with ab4183 (1/200). The RNF8 antibody gives a relatively weak yet predominantly nuclear staining pattern in interphase nuceli. ab4183 staining is shown in green. The cells were counterstained with DAPI (red).
Kirk McManus, University of British Columbia

All lanes : Anti-RNF8 antibody (ab4183) at 1 µg/ml
Lane 1 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate
Lane 2 : HeLa (Human epithelial carcinoma cell line) Nuclear Lysate
Lane 3 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate
Lane 4 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate with RNF8 peptide (ab24680) at 1 µg/ml
Lane 5 : HeLa (Human epithelial carcinoma cell line) Nuclear Lysate with RNF8 peptide (ab24680) at 1 µg/ml
Lane 6 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate with RNF8 peptide (ab24680) at 1 µg/ml
Lysates/proteins at 20 µg per lane.
Secondary
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Performed under reducing conditions.
Predicted band size : 55.5 kDa
Observed band size : 60 kDa (why is the actual band size different from the predicted?)
Exposure time : 3 minutes
1
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
